Pharma's Almanac TVPA TV
 
  • Follow the Journey
  • Companies We've Met
  • AES Clean Technology
  • Altis Biosystems
  • Arranta Bio
  • Avara Pharmaceutical Services
  • Avid Bioservices
  • BioVectra
  • Centaur BPS
  • Dynamk Capital
  • ECRI
  • Evolve Biologics
  • Federal Equipment Company
  • Globyz
  • Inceptor Bio
  • IPS-Integrated Project Services
  • Olon
  • Pii
  • Polpharma Biologics
  • PPD
  • RoosterBio
  • SanaClis
  • Sanofi AIS
  • SGD Pharma
  • SPI Pharma
  • TriRx Pharmaceutical Services
  • Yourway
Dashboard
Your Name
Your Email
  • Manage Account
  • Sign Out
Sign In
Register
    • Topics
        Products
        • ADC
        • API - Small Molecule
        • Biologics
        • Biopharmaceuticals
        • Biosimilars
        • Cell and Gene Therapy
        • DNA
        • Drug Product
        • Drug Substance
        • Equipment
        • Generics
        • Immunotherapy
        • Injectables
        • Monoclonal Antibody
        • Novel Therapeutics
        • Oral Solid Dosage
        • Orphan Drugs
        • Parenterals
        • Stem Cells
        • Vaccine
        Services
        • Big Data
        • Bioprocessing
        • Clinical Trials
        • Continuous Manufacturing
        • Diagnostics
        • Drug Delivery
        • Drug Development
        • Drug Discovery
        • Facility
        • Formulation
        • Innovation
        • Oncology
        • Patient Adherence
        • Patient Centric
        • Preclinical
        • Process Development
        • Quality
        • Regulatory
        • Research
        • Serialization
        Segment
        • Biomanufacturing
        • Biotechnology
        • CDMO
        • Consulting
        • CRO
        • Engineering
        • Equipment
        • Excipients
        • Healthcare
        • Intermediates
        • Logistics
        • Manufacturing
        • Packaging
        • Supply Chain
        Business
        • Agreement
        • Appointment
        • Business
        • Capacity Expansion
        • Collaboration
        • Growth
        • Investment
        • Licensing
        • M&A
        • Market Expansion
        • Market Intelligence
        • Market Prediction
        • New Facility
        • Strategic Partnership
    • Magazine
      • Current Issue
      • Archive
    • Reports
      • Biologics Pricing Report
      • Oral Solid Dose Market Report
    • Community
    • Company A to Z
    • Content Filter
    • More+
      • Staffing
      • Media Kit
      • By The Numbers

    Soligenix

    5 Articles Available

    Can't find what you're looking for? Try our advanced search.

    Phase III

    Soligenix Announces Phase 3 FLASH Study Continues to Demonstrate Positive Benefits in Patients with Cutaneous T-Cell Lymphoma
    PR-M10-20-14

    Fast Track

    FDA Grants Soligenix "Fast Track" Designation for RiVax® in the Prevention of Ricin Poisoning
    PR-M02-20-NI-019

    Clinical Trials

    Soligenix Announces Positive Recommendation on its Phase 3 Clinical Trial for the Treatment of Oral Mucositis
    PR-M09-19-NI-007

    Vaccine

    Soligenix Announces Publication Demonstrating Thermostabilization of an Ebola Subunit Vaccine Candidate
    PR-M02-19-NI-023

    Phase 3

    Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX301
    PR-M10-18-NI-054

    About Us
    That’s Nice Staffing By The Numbers
    More
    Media Kit Download Current Issue
    Your Account
    Manage Your Account Dashboard Sign Out
    Sign In Register
    Help
    Contact Us Support
    Nice Insight/That’s Nice

    89 Fifth Avenue
    Fifth Floor
    New York
    NY 10003-3020

    New York – San Diego – Chicago
    London – Frankfurt – Shanghai

    Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

    © PHARMA’S ALMANAC 2021 Terms and Conditions